| Model Number |
MCS-P3-26-AOA |
| Medical Device Problem Codes |
Insufficient Device Problem Information (3190); Device Stenosis (4066)
|
| Health Effect - Clinical Codes |
Aortic Valve Stenosis (1717); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/06/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that approximately 10 years following the implant of this transcatheter bioprosthetic valve, the valve failed.The mechanism of failure was not provided.No adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated b.5 and h.6 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that aortic stenosis was reported.There was a high risk for coronary occlusion and a valve-in-valve may be required.Medical management is being provided.
|
| |
|
Search Alerts/Recalls
|